Your browser doesn't support javascript.
loading
Effect of bevacizumab in advanced low grade serous ovarian cancer: Data from the MITO 22 trial.
Musacchio, Lucia; Turinetto, Margherita; Arenare, Laura; Bartoletti, Michele; Califano, Daniela; Tuninetti, Valentina; Marchetti, Claudia; Cormio, Gennaro; Loizzi, Vera; Pisano, Carmela; Salutari, Vanda; Valabrega, Giorgio; Priolo, Domenico; Cecere, Sabrina Chiara; Ventriglia, Jole; Raspagliesi, Francesco; Perrone, Francesco; Fagotti, Anna; Lorusso, Domenica; Scambia, Giovanni; Pignata, Sandro.
Afiliação
  • Musacchio L; Department of Women and Child Health, Division of Gynecologic Oncology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
  • Turinetto M; Department of Oncology, University of Torino at Ordine Mauriziano Hospital, Turin, Italy.
  • Arenare L; Clinical Trial Unit, Istituto Nazionale Tumori, IRCCS - Fondazione G.Pascale, Naples, Italy.
  • Bartoletti M; Unit of Medical Oncology and Cancer Prevention, Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Italy.
  • Califano D; Microenvironment Molecular Targets Unit, Istituto Nazionale Tumori, IRCCS - Fondazione G. Pascale, Naples, Italy.
  • Tuninetti V; Department of Oncology, University of Torino at Ordine Mauriziano Hospital, Turin, Italy.
  • Marchetti C; Department of Women and Child Health, Division of Gynecologic Oncology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
  • Cormio G; Gynecologic Oncology Istituto Tumori Giovanni Paolo II - IRCCS, Bari, Italy; Interdisciplinary Department of Medicine, University of Bari, Italy.
  • Loizzi V; Gynecologic Oncology Istituto Tumori Giovanni Paolo II - IRCCS, Bari, Italy; Interdisciplinary Department of Medicine, University of Bari, Italy.
  • Pisano C; Department of Urology and Gynecology, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale Napoli, Italy.
  • Salutari V; Department of Women and Child Health, Division of Gynecologic Oncology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
  • Valabrega G; Department of Oncology, University of Torino at Ordine Mauriziano Hospital, Turin, Italy.
  • Priolo D; Medical Oncology Department, San Vincenzo Hospital, Taormina, Messina, Italy.
  • Cecere SC; Department of Urology and Gynecology, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale Napoli, Italy.
  • Ventriglia J; Department of Urology and Gynecology, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale Napoli, Italy.
  • Raspagliesi F; Gynecologic Oncology Unit, Istituto Nazionale Tumori, IRCCS, Milan, Italy.
  • Perrone F; Clinical Trial Unit, Istituto Nazionale Tumori, IRCCS - Fondazione G.Pascale, Naples, Italy.
  • Fagotti A; Department of Women and Child Health, Division of Gynecologic Oncology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy; Department of Life Science and Public Health, Catholic University of Sacred Heart, Largo Agostino Gemelli, Rome, Italy.
  • Lorusso D; Department of Women and Child Health, Division of Gynecologic Oncology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy; Department of Life Science and Public Health, Catholic University of Sacred Heart, Largo Agostino Gemelli, Rome, Italy.
  • Scambia G; Department of Women and Child Health, Division of Gynecologic Oncology, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy; Department of Life Science and Public Health, Catholic University of Sacred Heart, Largo Agostino Gemelli, Rome, Italy.
  • Pignata S; Department of Urology and Gynecology, Istituto Nazionale Tumori IRCCS Fondazione G. Pascale Napoli, Italy. Electronic address: s.pignata@istitutotumori.na.it.
Gynecol Oncol ; 172: 72-77, 2023 05.
Article em En | MEDLINE | ID: mdl-36965291

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Neoplasias Peritoneais Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Neoplasias Peritoneais Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article